Sha Xiao Selected Research

Sha Xiao Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 07/2003
4	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2018
4	Xeroderma Pigmentosum (Kaposi's Disease) 01/2021 - 01/2012
3	Inflammation (Inflammations) 03/2024 - 01/2021
3	Pre-Eclampsia (Preeclampsia) 01/2023 - 09/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2007 - 07/2005
2	Hypertension (High Blood Pressure) 03/2024 - 09/2017
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2012
2	Carcinogenesis 12/2016 - 11/2004
2	Poisoning 01/2015 - 02/2013
2	Cholangiocarcinoma 04/2008 - 11/2004
2	Infections 04/2008 - 08/2005
1	Heart Diseases (Heart Disease) 12/2023
1	Stroke (Strokes) 10/2023
1	Heart Failure 10/2022
1	Venous Thromboembolism 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hemorrhage 01/2022
1	Postpartum Hemorrhage 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Mouth Neoplasms (Oral Cancer) 11/2017
1	Sick Building Syndrome 06/2017
1	Complementation Group B Xeroderma Pigmentosum 01/2015
1	Occupational Diseases (Occupational Disease) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2012
1	Aspergillosis 02/2008
1	Adenoma (Adenomas) 08/2007
1	Polyps 08/2007
1	Muscular Atrophy (Muscle Atrophy) 03/2006
1	Virus Diseases (Viral Diseases) 02/2006
1	Nasopharyngitis 02/2006

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 07/2018 - 11/2004
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2013
3	benzo(a)pyrene- 7,8- dihydrodiol- 9,10- epoxide- DNAIBA 12/2016 - 01/2013
3	NF-kappa B (NF-kB)IBA 04/2008 - 07/2005
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008 - 02/2006
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2018
2	celastrolIBA 07/2018 - 09/2017
2	Environmental CarcinogensIBA 08/2016 - 04/2013
2	Benzene (Benzole)IBA 01/2015 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 07/2003
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2005 - 07/2005
1	IonsIBA 03/2024
1	BL 11 (BL11)IBA 12/2023
1	Amino Acids FDA Link 06/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Activating Transcription Factor 2IBA 01/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Croton OilIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Glutathione PeroxidaseIBA 01/2021
1	Superoxide DismutaseIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	CatalaseIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AcetoneIBA 01/2021
1	boeravinone BIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	3'-(1-butylphosphoryl)adenosineIBA 01/2021
1	Deoxyribonuclease I (Nickase)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Adenosine Triphosphate (ATP)IBA 10/2018
1	NPHS2 proteinIBA 07/2018
1	arginine methyl esterIBA 07/2018
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2018
1	nephrinIBA 07/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2018
1	ORALIT (ORS)IBA 01/2018
1	4-O-methylhonokiolIBA 11/2017
1	TriterpenesIBA 09/2017
1	Nifedipine (Adalat)FDA LinkGeneric 09/2017
1	Formaldehyde (Formol)FDA Link 06/2017
1	Organic Chemicals (Chemicals, Organic)IBA 06/2017
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 12/2016
1	ElementsIBA 08/2016
1	Protein Phosphatase 1IBA 01/2015
1	trans-1,2-dihydro-1,2-naphthalenediolIBA 04/2013
1	Epoxy Compounds (Epoxides)IBA 04/2013
1	Benzo(a)pyreneIBA 04/2013
1	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 04/2013
1	DNA AdductsIBA 02/2013
1	Oxygen (Dioxygen)IBA 03/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2012
1	galactomannanIBA 02/2008
1	EpitopesIBA 02/2008
1	Fibroblast Growth Factor 1 (FGF-1)IBA 03/2006
1	CollagenIBA 03/2006

Therapy/Procedure

2	Patient Readmission 10/2023 - 10/2022
1	Therapeutics 10/2022
1	Oral Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2012